Fluorinated amino acids for tumour imaging with positron emission tomography.
about
Positron emission tomography imaging of prostate cancerMolecular and functional imaging technology for the development of efficient treatment strategies for gliomas.SPECT and PET serve as molecular imaging techniques and in vivo biomarkers for brain metastases.Metabolism of no-carrier-added 2-[18F]fluoro-L-tyrosine in rats.Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapyLAT-1 based primary breast cancer detection by [99m]Tc-labeled DTPA-bis-methionine scintimammography: first results using indigenously developed single vial kit preparation.A convenient photocatalytic fluorination of unactivated C-H bonds.Metabolic positron emission tomography imaging in cancer detection and therapy response.The role of DNA synthesis imaging in cancer in the era of targeted therapeuticsPositron emission tomography in cancer research and treatment.The next generation of positron emission tomography radiopharmaceuticals in oncology.Role of FDG-PET in the diagnosis and treatment of colorectal liver metastases.Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas.Targeted molecular imaging in oncology: focus on radiation therapy.Synthesis and Biological Evaluation of (S)-Amino-2-methyl-4-[(76)Br]bromo-3-(E)-butenoic Acid (BrVAIB) for Brain Tumor Imaging.18F-AFETP, 18F-FET, and 18F-FDG imaging of mouse DBT gliomas.Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.Chiral nickel(II) complexes in the preparation of 11C- and 18F-labelled enantiomerically pure α-amino acids.Current molecular imaging positron emitting radiotracers in oncology.System a amino acid transport-targeted brain and systemic tumor PET imaging agents 2-amino-3-[(18)F]fluoro-2-methylpropanoic acid and 3-[(18)F]fluoro-2-methyl-2-(methylamino)propanoic acid.Synthesis, radiolabeling, and biological evaluation of (R)- and (S)-2-amino-3-[(18)F]fluoro-2-methylpropanoic acid (FAMP) and (R)- and (S)-3-[(18)F]fluoro-2-methyl-2-N-(methylamino)propanoic acid (NMeFAMP) as potential PET radioligands for imaging bSynthesis, uptake mechanism characterization and biological evaluation of (18)F labeled fluoroalkyl phenylalanine analogs as potential PET imaging agents.Fluorine-18 labeled amino acids for tumor PET/CT imagingThe Potential Benefit by Application of Kinetic Analysis of PET in the Clinical Oncology.Comparative diagnostic accuracy of contrast-enhanced MRI and (18)F-FDOPA PET-CT in recurrent glioma.18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT.Carbon-11 and Fluorine-18 Labeled Amino Acid Tracers for Positron Emission Tomography Imaging of Tumors.Synthesis and physical chemical properties of 2-amino-4-(trifluoromethoxy)butanoic acid - a CF3O-containing analogue of natural lipophilic amino acids.¹⁸F-fluorodopa positron-emission tomography: an emerging imaging modality for patients with brain metastases.Synthesis of deuterium-labelled halogen derivatives of L-tryptophan catalysed by tryptophanase.
P2860
Q24596241-4F020B91-3FFC-4C2F-939B-0E0A75D40E88Q30775012-AA61E186-5B83-463A-9FD6-B1ACC1F5EC7BQ30828977-4995B44F-ED37-4488-87D5-ED98DA8EF95EQ30850780-9C8D47D4-5B1B-4ED8-87F5-40BC521EBCC7Q33838502-C67430CA-2B75-4160-947B-ADF2C0C7354CQ34154609-A8E76EA3-3B11-42BE-AE67-244AC1ED82E0Q34412063-9C0F706E-A255-48AB-8364-A99D1104091FQ34786518-6E690A63-033B-4482-B00D-4DBBE8B2F85AQ34907192-B7A345CA-0AA5-4F17-A79E-502CBF47DB35Q35081118-A3AA8C0C-19F1-4A65-A4A4-CF363B5F9288Q35525690-D62F5334-7435-4B76-ACF4-E398E8E24A38Q35843694-19CA393F-8666-4956-82F3-FFA55C3B2BC0Q36401835-1025D978-0915-4A39-ABA1-2D3966EFB1A8Q36528175-46182DED-1F18-4658-959E-9AE53B972389Q36609872-9F767E87-4375-417E-BB33-543C59319677Q37155873-7A32945A-DA02-4CDA-A7DE-5687DC2D3547Q37236103-2DB4526C-59FB-4AE3-AE23-2F0DCA75BDBCQ37967152-0CD4C58D-BF07-4B8A-835E-90D6A320EA01Q38217835-00D8798B-FD56-438C-BEFA-F3679441DB2BQ38952620-280474D9-AF20-4F20-A21B-6274378B92F5Q39557749-11052733-1F3C-4FD1-9988-CDC2EC862793Q39609869-E45928A7-3F05-4EBD-A030-FC229E659EFCQ41694062-176A2FB6-52F0-46B4-973A-BDBBFE2EC0B7Q42124600-582AEC2A-21F6-4F8A-BC27-26612AC48097Q45267961-75DA32B4-5F44-4F2B-A6A3-08506DC748E9Q46366163-04D27508-2FB6-4C49-BA05-C6F4D6D45EF8Q47833074-A47D87E9-778C-481D-97C0-E0D60A689E8DQ48152352-41266889-FF9D-4FCC-9BA2-5D4B8E1EFCDBQ48737939-60210B4A-962A-485F-BCF3-46CFA898D5AFQ54256268-654FC482-FD67-47AB-AFFB-7948752E2834
P2860
Fluorinated amino acids for tumour imaging with positron emission tomography.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Fluorinated amino acids for tumour imaging with positron emission tomography.
@ast
Fluorinated amino acids for tumour imaging with positron emission tomography.
@en
Fluorinated amino acids for tumour imaging with positron emission tomography.
@nl
type
label
Fluorinated amino acids for tumour imaging with positron emission tomography.
@ast
Fluorinated amino acids for tumour imaging with positron emission tomography.
@en
Fluorinated amino acids for tumour imaging with positron emission tomography.
@nl
prefLabel
Fluorinated amino acids for tumour imaging with positron emission tomography.
@ast
Fluorinated amino acids for tumour imaging with positron emission tomography.
@en
Fluorinated amino acids for tumour imaging with positron emission tomography.
@nl
P50
P1476
Fluorinated amino acids for tumour imaging with positron emission tomography.
@en
P2093
Frans H M Corstens
Wim J G Oyen
P2888
P304
P356
10.1007/S00259-001-0716-Y
P577
2002-01-11T00:00:00Z